{"id":70705,"date":"2026-05-12T09:29:41","date_gmt":"2026-05-12T09:29:41","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70705"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"oxytocin-acetate","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/oxytocin-acetate\/","title":{"rendered":"Oxitocina Acetato"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es el acetato de oxitocina?<\/h3>\n<p style=\"margin: 0;\"><strong>Oxitocina Acetato<\/strong> is the acetate-salt form of oxytocin, a 9-amino-acid cyclic neuropeptide with a single disulfide bridge between Cys1 and Cys6. It is one of the oldest and most extensively studied neuropeptides in published studies, acting as both a hypothalamic hormone (uterine contraction, milk ejection) and a central neuromodulator of social bonding, trust, and affiliative behaviour. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">50-56-6 (oxitocina en forma libre); suministrado como acetato<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>43<\/sub>H<sub>66<\/sub>N<sub>12<\/sub>O<sub>12<\/sub>S<sub>2<\/sub> (forma libre; el acetato a\u00f1ade el contrai\u00f3n CH\u2083COOH)<sub>3<\/sub>1007.19 Da (forma libre)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH\u2082<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">(CYIQNCPLG-NH\u2082, 9 amino\u00e1cidos; puente disulfuro intramolecular Cys1\u2013Cys6)<sub>2<\/sub> (CYIQNCPLG-NH<sub>2<\/sub>, 9 amino acids; intramolecular disulfide bridge Cys<sup>1<\/sup>\u2013Cys<sup>6<\/sup> formando un anillo macroc\u00edclico de 6 residuos con una cola C-terminal de 3 residuos; C-terminal amidado)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Sal de acetato liofilizada (polvo blanco a blanquecino)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar dentro de ~30 d\u00edas. Proteger de la luz. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es el acetato de oxitocina?<\/h2>\n<p><strong>Oxitocina Acetato<\/strong> is the acetate-salt form of oxytocin, a 9-amino-acid cyclic neuropeptide first isolated by Sir Henry Dale in 1906 and chemically synthesised by Vincent du Vigneaud in 1953 \u2014 the first peptide hormone ever produced by total synthesis, work that earned du Vigneaud the 1955 Nobel Prize in Chemistry. The acetate counterion is used in pharmaceutical-grade lyophilization because it improves long-term peptide stability and water solubility relative to free-base oxytocin without altering pharmacology \u2014 the acetate dissociates rapidly in physiological solution. The well-characterised sequence is CYIQNCPLG-NH<sub>2<\/sub> con un puente disulfuro intramolecular entre Cys1 y Cys6 que crea un anillo macroc\u00edclico de 6 residuos y una cola C-terminal de 3 residuos. El peso molecular es 1007.19 Da (base libre); f\u00f3rmula emp\u00edrica C. La oxitocina se suministra como un polvo liofilizado de alta pureza para su reconstituci\u00f3n con agua bacteriost\u00e1tica. La oxitocina farmac\u00e9utica est\u00e1 aprobada por la FDA como medicamento obst\u00e9trico inyectable (Pitocin, Syntocinon) para la inducci\u00f3n del parto y el control de la hemorragia posparto; el acetato de oxitocina de grado de investigaci\u00f3n que se vende aqu\u00ed se suministra<sub>43<\/sub>H<sub>66<\/sub>N<sub>12<\/sub>O<sub>12<\/sub>S<sub>2<\/sub>. Oxytocin is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For related small-peptide CNS studies, see our <a href=\"https:\/\/medsbase.com\/es\/selank\/\">Selank<\/a> y <a href=\"https:\/\/medsbase.com\/es\/pt-141\/\">PT-141<\/a> p\u00e1ginas de productos. <\/p>\n<h2>Lo que hace que la oxitocina sea inusual entre los p\u00e9ptidos de investigaci\u00f3n es su<\/h2>\n<p>What makes oxytocin unusual among peptides is its <strong>como hormona endocrina perif\u00e9rica y neuromodulador central. La misma mol\u00e9cula, liberada desde diferentes compartimentos anat\u00f3micos, produce efectos fisiol\u00f3gicos fundamentalmente diferentes:<\/strong> Liberaci\u00f3n endocrina perif\u00e9rica \u2014 efectos uterinos y mamarios<\/p>\n<ul>\n<li><strong>\u2014 La oxitocina se sintetiza en las neuronas magnocelulares de los n\u00facleos supra\u00f3ptico y paraventricular del hipot\u00e1lamo y se libera en la circulaci\u00f3n sist\u00e9mica desde la hip\u00f3fisis posterior. La oxitocina perif\u00e9rica se une a los receptores OXTR en el m\u00fasculo liso uterino (estimulando las contracciones durante el parto) y en las c\u00e9lulas mioepiteliales de los alv\u00e9olos mamarios (impulsando el reflejo de eyecci\u00f3n de leche). La vida media perif\u00e9rica es corta (~3\u20135 minutos IV) debido al metabolismo r\u00e1pido por la oxitocinasa y otras peptidasas.<\/strong> Liberaci\u00f3n central \u2014 comportamiento social, afiliativo y amortiguador del estr\u00e9s.<\/li>\n<li><strong>Central release \u2014 social, affiliative, and stress-buffering behaviour<\/strong> \u2014 A separate population of parvocellular oxytocin neurons projects axonally into brain regions including the amygdala, nucleus accumbens, ventral tegmental area, and prefrontal cortex. Central oxytocin release does not enter systemic circulation and is not measured by plasma assays. In published studies it modulates pair-bonding, in-group affiliation, trust, fear extinction, and stress reactivity. The prairie-vole pair-bonding literature is the canonical mechanistic dataset for central oxytocin signalling.<\/li>\n<li><strong>Farmacolog\u00eda de receptores y transducci\u00f3n de se\u00f1ales<\/strong> \u2014 La oxitocina act\u00faa sobre un \u00fanico receptor acoplado a prote\u00edna G (OXTR), que se acopla principalmente a G\u03b1<sub>q\/11<\/sub> para activar la fosfolipasa C, IP<sub>3<\/sub>, and intracellular calcium release in smooth muscle. In the CNS, OXTR signalling is more complex and includes G\u03b1<sub>y la liberaci\u00f3n de calcio intracelular en el m\u00fasculo liso. En el SNC, la se\u00f1alizaci\u00f3n del OXTR es m\u00e1s compleja e incluye el acoplamiento a G\u03b1<\/sub> coupling, modulation of GABAergic interneurons, and crosstalk with the closely-related vasopressin V1a receptor. Selective OXTR agonists and antagonists are heavily used in current studies to dissect oxytocin vs vasopressin contributions to behaviour.<\/li>\n<\/ul>\n<p>The intranasal administration route is one of the most-cited studies delivery methods because it produces measurable CNS effects on social behaviour without raising peripheral plasma oxytocin to physiologically meaningful levels. The exact mechanism by which intranasal oxytocin reaches CNS compartments \u2014 whether through olfactory and trigeminal nerve transport, cribriform plate diffusion, or a peripheral feedback signal \u2014 remains an active studies question. The behavioural effects are reproducible enough that intranasal administration has become the standard route in human and rodent oxytocin behavioural support. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Oxytocin Acetate is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Comportamiento social y formaci\u00f3n de v\u00ednculos de pareja<\/strong> \u2014 pruebas de preferencia de pareja en topillos de la pradera, formaci\u00f3n de preferencia de pareja en topillos mon\u00f3gamos vs pol\u00edgamos, paradigmas de reconocimiento social en roedores (Insel &amp; Hulihan, Behav Neurosci 1995; Young &amp; Wang, Nat Neurosci 2004)<\/li>\n<li><strong>Autism spectrum and social-cognition studies<\/strong> \u2014 preclinical models of social-deficit phenotypes, OXTR variant cohort studies, intranasal oxytocin behavioural endpoints; one of the most active areas of contemporary oxytocin clinical studies<\/li>\n<li><strong>Trust and cooperation behavioural support<\/strong> \u2014 paradigmas econ\u00f3micos del juego de la confianza, toma de decisiones cooperativas bajo incertidumbre; modulaci\u00f3n del sesgo endogrupo vs exogrupo<\/li>\n<li><strong>Estr\u00e9s, ansiedad y extinci\u00f3n del miedo<\/strong> \u2014 amygdala-dependent fear conditioning, stress-induced HPA-axis activation, cortisol response modulation in published studies<\/li>\n<li><strong>Comportamiento maternal y cuidado parental<\/strong> \u2014 postpartum maternal-behaviour induction in rodents, paternal-care studies in monogamous vole species, alloparental behaviour<\/li>\n<li><strong>Reproductive physiology studies<\/strong> \u2014 uterine contractility assays, mammary myoepithelial-cell studies, labour and parturition mechanism studies<\/li>\n<li><strong>Cicatrizaci\u00f3n de heridas y regeneraci\u00f3n tisular<\/strong> \u2014 OXTR expression on dermal fibroblasts and keratinocytes; emerging studies on local oxytocin signalling in cutaneous wound repair<\/li>\n<li><strong>Comparative neuropeptide studies<\/strong> \u2014 comparaci\u00f3n con la vasopresina (un neurop\u00e9ptido c\u00edclico de 9 amino\u00e1cidos estrechamente relacionado con una diferencia de un amino\u00e1cido) y con otros p\u00e9ptidos peque\u00f1os activos en el SNC como <a href=\"https:\/\/medsbase.com\/es\/selank\/\">Selank<\/a>.<\/li>\n<\/ul>\n<p>Para un contexto m\u00e1s amplio sobre d\u00f3nde encaja la oxitocina en el panorama de los neuromoduladores de peque\u00f1os p\u00e9ptidos, consulte <a href=\"https:\/\/medsbase.com\/es\/selank\/\">Selank<\/a> (heptap\u00e9ptido ansiol\u00edtico), <a href=\"https:\/\/medsbase.com\/es\/pt-141\/\">PT-141<\/a> (agonista de melanocortina activo en el SNC), y <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a> (heptap\u00e9ptido nootr\u00f3pico). Explore el <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para compuestos relacionados. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase stocks Oxytocin Acetate in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, intranasal-vehicle formulation, behavioural-test protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended-cycle studies, lowest per-mg cost, multi-cohort behavioural studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized acetate-salt powder, 99%+ HPLC purity). Because oxytocin&#8217;s dose range is in the low-microgram-per-administration regime, a single 5\u00a0mg vial supports many weeks of behavioural support at typical intranasal doses (24\u00a0IU \u2248 40\u00a0mcg per administration in human studies, with rodent doses scaled lower). <\/p>\n<h2>C\u00f3mo se compara \u2014 Acetato de Oxitocina vs Selank<\/h2>\n<p>La oxitocina y <a href=\"https:\/\/medsbase.com\/es\/selank\/\">Selank<\/a> are both small CNS-active peptides used in behavioural and mood-axis studies, but they target different receptors and behavioural domains. They are sometimes compared in studies because both are intranasally bioavailable and both produce measurable behavioural effects in published rodent and human studies despite being structurally and pharmacologically unrelated. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Oxitocina Acetato<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longitud<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">9 amino\u00e1cidos (nonap\u00e9ptido c\u00edclico)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino\u00e1cidos (heptap\u00e9ptido lineal)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Estructura<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Macrociclo puente disulfuro<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Lineal con extremo C amidado<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Receptor primario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">OXTR (acoplado a prote\u00edna G)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No cl\u00e1sico (modulaci\u00f3n GABA, BDNF)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Se\u00f1al conductual<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Vinculaci\u00f3n social, confianza, comportamiento afiliativo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiol\u00edtico, resiliencia al estr\u00e9s<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">24\u201340 UI (~40\u201365 mcg)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 mcg<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Vida media plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~3\u20135 min (IV)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~15\u201330 min (intranasal)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico aprobado<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Inducci\u00f3n del parto, hemorragia posparto<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiol\u00edtico (solo en Rusia)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For behavioural-stacking, the two peptides have non-overlapping mechanisms (oxytocin acts on its own GPCR; Selank acts via GABA\/BDNF modulation), so co-administration is not pharmacologically redundant. Study protocols studying stress and social behaviour as joint endpoints sometimes use both arms. <\/p>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> Almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original para existencias de trabajo a corto plazo. Para almacenamiento a largo plazo sin abrir, congele a \u221220 \u00b0C. La oxitocina acetato liofilizada es estable bajo refrigeraci\u00f3n hasta 24 meses y a \u221220 \u00b0C hasta 36 meses. Evite ciclos de congelaci\u00f3n-descongelaci\u00f3n en el polvo liofilizado. La forma de sal acetato es m\u00e1s higrosc\u00f3picamente estable que la base libre, pero los viales a\u00fan deben protegerse de la humedad atmosf\u00e9rica. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 5.0\u00a0mL of bacteriostatic water yields a 1\u00a0mg\/mL working concentration; 0.04\u00a0mL delivers a 40\u00a0mcg dose (~24\u00a0IU). Swirl gently \u2014 do <strong>ajuste<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>Despu\u00e9s de la reconstituci\u00f3n:<\/strong> Almacene refrigerado a 2\u20138 \u00b0C y utilice dentro de los 30 d\u00edas para una estabilidad \u00f3ptima. No congele la soluci\u00f3n reconstituida \u2014 los ciclos de congelaci\u00f3n-descongelaci\u00f3n degradan la integridad del p\u00e9ptido y alteran el enlace disulfuro Cys1\u2013Cys6. Deseche cualquier vial que muestre turbidez, precipitado o decoloraci\u00f3n. <\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3>What is Oxytocin Acetate used for in studies?<\/h3>\n<p>Oxytocin Acetate is used in studies investigating social behaviour and pair-bonding, autism spectrum and social cognition, trust and cooperation paradigms, stress and fear extinction, maternal and parental care, reproductive physiology, and wound healing. It is one of the most extensively studied neuropeptides in the published literature and serves as the canonical OXTR-axis compound. The pharmaceutical-grade oxytocin acetate sold here is <strong>ajuste<\/strong> FDA-approved for non-clinical human use and is supplied strictly for clinical studies. <\/p>\n<h3>\u00bfCu\u00e1l es la diferencia entre el acetato de oxitocina y la oxitocina en base libre?<\/h3>\n<p>The acetate counterion does not alter pharmacology \u2014 it dissociates rapidly in physiological solution. The acetate salt is used in pharmaceutical-grade peptide lyophilization because it improves long-term peptide stability, reduces hygroscopicity, and improves aqueous solubility relative to free-base oxytocin. All published behavioural and endocrine effects of oxytocin apply to the acetate salt at equivalent oxytocin content. <\/p>\n<h3>\u00bfEn qu\u00e9 se diferencia la oxitocina del Selank?<\/h3>\n<p>Both are small CNS-active peptides used in behavioural support, but they target different receptors and behavioural domains. Oxytocin is a 9-amino-acid disulfide-bridged macrocyclic peptide that binds the OXTR G-protein-coupled receptor, with primary signal in social bonding and trust paradigms. Selank is a 7-amino-acid linear heptapeptide that acts via GABA modulation and BDNF expression, with primary signal in anxiolysis and stress resilience. The two are pharmacologically unrelated. <\/p>\n<h3>What is the typical Oxytocin dose?<\/h3>\n<p>Published human intranasal protocols typically use 24\u201340\u00a0IU per administration (1\u00a0IU \u2248 1.7\u00a0mcg, so 24\u00a0IU \u2248 40\u00a0mcg). Rodent doses are scaled lower in absolute mass but higher in mg\/kg. A 5\u00a0mg vial reconstituted with 5.0\u00a0mL bacteriostatic water yields 1\u00a0mg\/mL \u2014 40\u00a0mcg per 0.04\u00a0mL. <\/p>\n<h3>\u00bfEst\u00e1 aprobado el acetato de oxitocina por la FDA?<\/h3>\n<p>Pharmaceutical injectable oxytocin (Pitocin, Syntocinon) is FDA-approved for specific obstetric indications \u2014 labour induction, postpartum haemorrhage control, and milk-letdown facilitation \u2014 manufactured to GMP standards by approved pharmaceutical manufacturers. <\/p>\n<h3>\u00bfC\u00f3mo se debe almacenar el acetato de oxitocina?<\/h3>\n<p>Viales liofilizados: refrigerados a 2\u20138 \u00b0C para existencias de trabajo a corto plazo, o a \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Soluci\u00f3n reconstituida: refrigerada a 2\u20138 \u00b0C, usar dentro de los 30 d\u00edas. No congele la soluci\u00f3n reconstituida \u2014 los ciclos de congelaci\u00f3n-descongelaci\u00f3n degradan el p\u00e9ptido y pueden alterar el puente disulfuro. Proteja de la luz directa en todo momento. <\/p>\n<h3>\u00bfC\u00f3mo reconstituyo el acetato de oxitocina?<\/h3>\n<p>Siga el procedimiento de reconstituci\u00f3n anterior. A\u00f1ada agua bacteriost\u00e1tica por la pared lateral del vial (no sobre el polvo liofilizado), agite suavemente y permita de 2 a 5 minutos para la disoluci\u00f3n completa. No <strong>ajuste<\/strong> Agite el vial \u2014 la agitaci\u00f3n vigorosa puede alterar el enlace disulfuro. Una soluci\u00f3n correctamente reconstituida es clara e incolora. Para un vial de 5 mg + 5,0 mL de diluyente, la concentraci\u00f3n de trabajo es de 1 mg\/mL. <\/p>\n<h3>\u00bfQu\u00e9 concentraciones tiene MedsBase en stock?<\/h3>\n<p>MedsBase carries Oxytocin Acetate in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Oxytocin be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is one of the most-cited studies delivery routes for oxytocin behavioural studies. Intranasal oxytocin produces measurable CNS effects on social behaviour, trust, and stress reactivity without raising peripheral plasma oxytocin to physiologically meaningful levels. The exact mechanism of CNS access remains an active studies question (olfactory and trigeminal nerve transport, cribriform plate diffusion, or peripheral feedback). Subcutaneous and intracerebroventricular routes are also documented in rodent studies. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media de la oxitocina?<\/h3>\n<p>In published studies, oxytocin has a plasma half-life of approximately 3\u20135 minutes following intravenous administration. The short peripheral half-life is due to rapid metabolism by oxytocinase (also called cystinyl aminopeptidase) and other peptidases. Behavioural effects following intranasal administration outlast plasma clearance because central oxytocin compartments are distinct from peripheral circulation. <\/p>\n<h3>\u00bfPor qu\u00e9 es importante el puente disulfuro?<\/h3>\n<p>El enlace disulfuro Cys1\u2013Cys6 bloquea la oxitocina en la conformaci\u00f3n c\u00edclica necesaria para la uni\u00f3n al receptor. La reducci\u00f3n del enlace disulfuro convierte la oxitocina en una forma lineal inactiva \u2014 por eso los procedimientos de reconstituci\u00f3n evitan espec\u00edficamente la agitaci\u00f3n vigorosa y los ciclos de congelaci\u00f3n-descongelaci\u00f3n, que pueden alterar el puente y degradar la actividad del p\u00e9ptido. El neurop\u00e9ptido estrechamente relacionado vasopresina tiene la misma arquitectura de puente disulfuro con solo una diferencia de amino\u00e1cido en la posici\u00f3n 3 (Phe en vasopresina frente a Ile en oxitocina). <\/p>\n<h3>Does Oxytocin cause side reported effects?<\/h3>\n<p>The most consistent finding in oxytocin is dose-dependence of behavioural effects \u2014 the response is not monotonic at high doses, and very large doses can produce paradoxical effects. Acute peripheral effects can include uterine contraction (relevant in pregnancy study models) and modest vasoactive effects at supraphysiological doses. Long-term behavioural support has reported context-dependent effects \u2014 e.g., increased in-group affiliation can be accompanied by increased out-group bias in some social-cognition paradigms. <\/p>\n<h3>How long does Oxytocin take to show effects in preclinical studies?<\/h3>\n<p>Acute behavioural effects on social-recognition, partner-preference, and trust-game paradigms are detectable within 30\u201360 minutes of intranasal administration in human and rodent studies. Peripheral effects (uterine contraction, milk-ejection) occur within seconds of intravenous administration due to direct OXTR coupling to PLC\/IP<sub>3<\/sub>\u00bfPuedo pedir acetato de oxitocina para env\u00edo internacional?<sup>2+<\/sup> S\u00ed. MedsBase env\u00eda acetato de oxitocina a todo el mundo desde nuestra red de env\u00edos dedicada a p\u00e9ptidos. Los pedidos que solo contienen p\u00e9ptidos califican para nuestro servicio de env\u00edo exclusivo para p\u00e9ptidos. Todos los pedidos se env\u00edan en embalaje con control de temperatura, con seguimiento completo y est\u00e1n cubiertos por nuestra. <\/p>\n<h3>Otros p\u00e9ptidos para investigaci\u00f3n del SNC, conductual y afectiva<\/h3>\n<p>\u2014 Agonista del receptor de melanocortina \u2014 Peque\u00f1o p\u00e9ptido activo en el SNC para investigaci\u00f3n de conducta sexual <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for CNS, Behavioural, and Affective Studies<\/h2>\n<ul>\n<li><a href=\"\/es\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide tuftsin analog \u2014 GABA\/BDNF stress resilience<\/li>\n<li><a href=\"\/es\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Heptap\u00e9ptido nootr\u00f3pico desarrollado en Rusia \u2014 modulaci\u00f3n melanocortina y dopamin\u00e9rgica<\/li>\n<li><a href=\"\/es\/pt-141\/\"><strong>PT-141 (Bremelanotide)<\/strong><\/a> \u2014 Melanocortin receptor agonist \u2014 CNS-active small peptide for sexual-behaviour studies<\/li>\n<li><a href=\"\/es\/epitalon\/\"><strong>Epital\u00f3n<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tissue-recovery<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore CNS-active peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Explora toda la <a href=\"https:\/\/medsbase.com\/es\/peptides\/\"><strong>cat\u00e1logo de p\u00e9ptidos<\/strong><\/a>, con compuestos relacionados que incluyen <a href=\"https:\/\/medsbase.com\/es\/selank\/\">Selank<\/a> for anxiolytic GABA-axis studies, <a href=\"https:\/\/medsbase.com\/es\/semax\/\">Semax<\/a> for nootropic melanocortin-axis studies, and <a href=\"https:\/\/medsbase.com\/es\/pt-141\/\">PT-141<\/a> for melanocortin sexual-behaviour studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Neurop\u00e9ptido c\u00edclico de 9 amino\u00e1cidos<br \/>\n\u2705 Agonista del receptor OXTR<br \/>\n\u2705 Social-bonding &amp; affiliative behavioural support<br \/>\n\u2705 P\u00e9ptido biodisponible por v\u00eda intranasal<br \/>\n\u2705 Forma de acetato \u2014 mayor estabilidad<\/p>\n<p><strong>Oxitocina Acetato<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70970,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6274,5441],"class_list":["post-70705","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-oxytocin","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/70705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=70705"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70970"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=70705"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=70705"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=70705"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=70705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}